Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Cardiology Reports
Erschienen in: Current Cardiology Reports 8/2023

08.07.2023 | Diversity and Health Equity in Cardiology (AE Johnson, Section Editor)

Incidence and Prevalence of Atrial Fibrillation in Latinos: What’s New Since the Study in Latinos (SOL)?

verfasst von: Apurva Khedagi, Francis Ugowe, Larry R. Jackson

Erschienen in: Current Cardiology Reports | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To assess contemporary epidemiological trends in AF incidence and prevalence in the LatinX population after the Hispanic Community Health Study/Study of Latinos.

Recent Findings

Atrial fibrillation (AF) remains the most abnormal heart rhythm condition globally and disproportionately impacts morbidity and mortality of communities that have been historically disadvantaged. The incidence and prevalence of AF is lower in the LatinX population compared to White individuals despite a higher burden of classic risk factors associated with AF. Since the Hispanic Community Health Study/Study of Latinos study on AF, recent data continues to demonstrate a similar lower burden of AF in the LatinX population compared to White individuals. However, the rates of incident AF may be accelerating faster in the LatinX population compared to their White counterparts. Furthermore, studies have found environmental and genetic risk factors that are associated with the development of AF within LatinX individuals, which may help explain the rising development of AF among the LatinX community. Recent research continues to show that LatinX populations are less likely to be treated with stroke reduction and rhythm control strategies and have a disproportionately higher burden of poor outcomes associated with AF compared to White patients.

Summary

Our review illuminates that further inclusion of LatinX individuals in AF randomized control trials and observational studies is imperative to understand the incidence and prevalence of AF in the LatinX community and improve overall morbidity and mortality.
Literatur
1.
Schnabel RB et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. The Lancet. 2015;386(9989):154–62.CrossRef
2.
Go AS et al. Prevalence of diagnosed atrial fibrillation in adults national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–5.CrossRefPubMed
3.
Heckbert SR et al. Differences by race/ethnicity in the prevalence of clinically detected and monitor-detected atrial fibrillation. Circ Arrhythm Electrophysiol. 2020;13(1):e007698.
4.
Rodriguez CJ et al. Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis. Ann Epidemiol. 2015;25(2):71–6.
5.
Borzecki AM et al. Racial differences in the prevalence of atrial fibrillation among males. J Natl Med Assoc. 2008;100(2):237–45.PubMed
6.
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–8.CrossRefPubMed
7.
8.
9.
Linares JD et al. Prevalence of atrial fibrillation and association with clinical, sociocultural, and ancestral correlates among Hispanic/Latinos: the Hispanic Community Health Study/Study of Latinos. Heart Rhythm. 2019;16(5):686–93.CrossRefPubMedPubMedCentral
10.
•• Alonso A et al. Epidemiology of atrial fibrillation in the All of Us Research Program. PLOS ONE. 2022;17(3):e0265498. This prospective cohort study found that in Hispanic participants recruited for the All of Us Research Program from 2017 to 2019, the prevalence of atrial fibrillation (AF) was 1.8% and the incidence of newly diagnosed AF was less than 5.9%. The findings of this study also noted that the rate of incident AF was higher in Hispanic participants compared to non-Hispanic White participants.
11.
Dewland TA et al. Incident atrial fibrillation among Asians Hispanics Blacks and Whites. Circulation. 2013;128(23):2470–7.CrossRefPubMed
12.
Essien UR et al. Disparities in anticoagulant therapy initiation for incident atrial fibrillation by race/ethnicity among patients in the Veterans Health Administration system. JAMA Netw Open. 2021;4(7):e2114234.CrossRefPubMedPubMedCentral
13.
14.
15.
Lloyd-Jones DM et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110(9):1042–6.CrossRefPubMed
16.
Alonso A et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009;158(1):111–7.CrossRefPubMedPubMedCentral
17.
Osman M et al. Racial differences in the prevalence of diagnosed atrial fibrillation among hospitalized patients. Mayo Clin Proc. 2021;96(9):2495–7.CrossRefPubMed
18.
Reinhardt SW et al. National trends in the burden of atrial fibrillation during hospital admissions for heart failure. J Am Heart Assoc. 2021;10(11):e019412.CrossRefPubMedPubMedCentral
19.
Laslett DB et al. Racial differences in the incidence of atrial fibrillation after cryptogenic stroke. Heart Rhythm. 2021;18(6):847–52.CrossRefPubMed
20.
Shulman E et al. Relative contribution of modifiable risk factors for incident atrial fibrillation in Hispanics, African Americans and non-Hispanic Whites. Int J Cardiol. 2019;275:89–94.CrossRefPubMed
21.
Chalazan B et al. Association of rare genetic variants and early-onset atrial fibrillation in ethnic minority individuals. JAMA Cardiol. 2021;6(7):811–9.CrossRefPubMedPubMedCentral
22.
Gonzalez-Cordero AF et al. Insight on the genetics of atrial fibrillation in Puerto Rican Hispanics. Stroke Res Treat. 2021;8819896.PubMedPubMedCentral
23.
• Essien UR et al. Association of race and ethnicity with oral anticoagulation and associated outcomes in patients with atrial fibrillation: findings from the Get With The Guidelines-Atrial Fibrillation Registry. JAMA Cardiol. 2022;7(12):1207–17. This retrospective cohort study using data from the Get With The Guidelines-Atrial Fibrillation registry found that patients hospitalized with AF who identified as Hispanic were the least likely to be prescribed an oral anticoagulant on discharge compared to patients of other racial and ethnic groups and Hispanic patients had a higher stroke risk than White patients.CrossRefPubMed
24.
Chen LY et al. CHA2DS2-VASc score and stroke prediction in atrial fibrillation in Whites, Blacks, and Hispanics. Stroke. 2019;50(1):28–33.CrossRefPubMed
25.
Mentias A et al. Racial and sex disparities in anticoagulation after electrical cardioversion for atrial fibrillation and flutter. J Am Heart Assoc. 2021;10(17):e021674.CrossRefPubMedPubMedCentral
26.
Eberly LA et al. Racial/ethnic and socioeconomic disparities in management of incident paroxysmal atrial fibrillation. JAMA Netw Open. 2021;4(2):e210247.CrossRefPubMedPubMedCentral
27.
Khan MZ et al. Representation of women, older patients, ethnic, and racial minorities in trials of atrial fibrillation. Pacing Clin Electrophysiol. 2021;44(3):423–31.CrossRefPubMedPubMedCentral
28.
• Sarraju A, Maron DJ, Rodriguez F. Under-reporting and under-representation of racial/ethnic minorities in major atrial fibrillation clinical trials. JACC: Clin Electrophysiol. 2020;6(6):739–41. Findings of this study note that only six of the 34 global clinical trials that formed the 2019 American Heart Association/American College of Cardiology/Heart Rhythm Society guidelines for AF reported Hispanic participants and Hispanic participants made up only 5.6% of the total study population of the six clinical trials which reported Hispanic participants.
29.
Nunes JC et al. Underrepresentation of ethnic and racial minorities in atrial fibrillation clinical trials. Circulation: Arrhythmia and Electrophysiology. 2021;14(12):e010452.
30.
31.
Hoyt H et al. Demographic profile of patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(9):994–8.CrossRefPubMed
32.
Bhave PD et al. Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm. 2015;12(7):1406–12.CrossRefPubMedPubMedCentral
33.
34.
Golwala H et al. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. Am Heart J. 2016;174:29–36.CrossRefPubMed
35.
Kapoor A et al. Disparities in anticoagulation use by race and ethnicity in long-term care residents with atrial fibrillation. J Am Heart Assoc. 2021;10(23):e023428.CrossRefPubMedPubMedCentral
36.
Essien UR et al. Race/ethnicity and sex-related differences in direct oral anticoagulant initiation in newly diagnosed atrial fibrillation: a retrospective study of Medicare data. J Natl Med Assoc. 2020;112(1):103–8.PubMed
37.
38.
Bush D et al. Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial. J Natl Med Assoc. 2006;98(3):330–9.PubMedPubMedCentral
39.
Gomez SE et al. Racial, ethnic, and sex disparities in atrial fibrillation management: rate and rhythm control. J Interv Card Electrophysiol. 2022.
Metadaten
Titel
Incidence and Prevalence of Atrial Fibrillation in Latinos: What’s New Since the Study in Latinos (SOL)?
verfasst von
Apurva Khedagi
Francis Ugowe
Larry R. Jackson
Publikationsdatum
08.07.2023
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 8/2023
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-023-01910-w

Weitere Artikel der Ausgabe 8/2023

Current Cardiology Reports 8/2023 Zur Ausgabe

Public Health Policy (SS Virani and D Mahtta, Section Editors)

Broadening Heart Failure Care Beyond Cardiology: Challenges and Successes Within the Landscape of Multidisciplinary Heart Failure Care

Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Risk of Cardiac Implantable Electronic Device Infection in Patients with Bloodstream Infection: Microbiologic Effect in the Era of Positron Emission Tomography–Computed Tomography

Heart Failure (HJ Eisen, Section Editor)

COVID-19 and Acute Cardiac Injury: Clinical Manifestations, Biomarkers, Mechanisms, Diagnosis, and Treatment

Cardio-Oncology (LA Baldassarre, Section Editor)

Approaches to Prevent and Manage Cardiovascular Disease in Patients Receiving Therapy for Prostate Cancer

Correction

Correction to: Echo Doppler Parameters of Diastolic Function

Nuclear Cardiology (V Dilsizian, Section Editor)

The Potential Role of PET in the Management of Peripheral Artery Disease

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen